OpenAI to allow adult erotica, but Microsoft opposes, highlighting industry split on intimacy-simulating AI.
Multiple teams, including the Cubs, eye free agent Dylan Cease as the Padres face roster turnover this offseason.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
OpenAI to allow adult erotica, but Microsoft opposes, highlighting industry split on intimacy-simulating AI.
Multiple teams, including the Cubs, eye free agent Dylan Cease as the Padres face roster turnover this offseason.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.